DIY artificial pancreas systems: the clinician perspective

人工胰腺 医学 胰岛素泵 胰岛素释放 欧洲联盟 1型糖尿病 食品药品监督管理局 互操作性 胰岛素 糖尿病 医疗保健 重症监护医学 风险分析(工程) 计算机科学 业务 内科学 内分泌学 万维网 经济政策 经济增长 经济
作者
Emma G Wilmot,Thomas Danne
出处
期刊:The Lancet Diabetes & Endocrinology [Elsevier BV]
卷期号:8 (3): 183-185 被引量:20
标识
DOI:10.1016/s2213-8587(19)30416-4
摘要

We are witnessing a technological revolution in type 1 diabetes, with a race to bring commercial closed-loop (artificial pancreas) systems to market. However, only one automated insulin-delivery system, the Medtronic MiniMed 670G, has received both US Food and Drug Administration (FDA) and European CE mark approval and is commercially available in several countries. The French Diabeloop system, designed to work with several continuous glucose monitors and insulin pumps, has received a CE mark, and the FDA have awarded the Tandem Diabetes Care t:slim X2 the status of an alternate controller enabled interoperable pump, facilitating efficient premarket review; however, neither are commercially available yet. Meanwhile, in the European Union, new medical device regulations will be more demanding with respect to safety, potentially slowing access to commercial closed-loop systems. While waiting for these systems to come to market, people living with diabetes have taken development into their own hands, with the #WeAreNotWaiting movement supporting the use of do-it-yourself (DIY) artificial pancreas systems incorporating commercially available insulin pumps and continuous glucose monitors with automated control algorithms. Several DIY artificial pancreas systems are now available for people to build and use, integrating a range of different insulin pumps and glucose sensors. Health-care professional opinions of DIY artificial pancreas systems in the UKType 1 diabetes is one of the most challenging long-term medical conditions to manage. Over the past five years, technologically skilled people with type 1 diabetes have developed communication systems and algorithms that allow insulin delivery from insulin pumps to be automatically controlled. These systems combine glucose data from a continuous glucose monitor with an original algorithm that communicates with an insulin pump to sustain, reduce, or increase insulin delivery to maintain glucose levels within a target range. Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
云深不知处完成签到,获得积分10
1秒前
康丽完成签到,获得积分10
1秒前
3秒前
橘酥酥呀完成签到,获得积分20
3秒前
3秒前
Ava应助微眠采纳,获得10
3秒前
向浩完成签到,获得积分10
3秒前
英姑应助科研通管家采纳,获得10
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
CCY完成签到,获得积分10
4秒前
领导范儿应助科研通管家采纳,获得10
4秒前
Orange应助科研通管家采纳,获得10
4秒前
4秒前
long应助科研通管家采纳,获得10
5秒前
5秒前
FashionBoy应助科研通管家采纳,获得10
5秒前
5秒前
斯文败类应助科研通管家采纳,获得10
5秒前
Ava应助科研通管家采纳,获得10
5秒前
Wind应助小鲤鱼采纳,获得20
5秒前
星辰大海应助科研通管家采纳,获得10
5秒前
Lyg发布了新的文献求助10
5秒前
彭于晏应助科研通管家采纳,获得10
5秒前
淡定从凝完成签到,获得积分10
5秒前
5秒前
量子星尘发布了新的文献求助10
6秒前
wnche完成签到,获得积分10
6秒前
月光族完成签到,获得积分10
6秒前
小小完成签到,获得积分20
6秒前
6秒前
Oil发布了新的文献求助10
6秒前
领导范儿应助向阳采纳,获得10
6秒前
1111完成签到,获得积分10
7秒前
8秒前
阿治发布了新的文献求助10
9秒前
SRY完成签到,获得积分10
9秒前
可爱的从寒完成签到,获得积分10
10秒前
10秒前
Hello应助burger采纳,获得10
10秒前
1111发布了新的文献求助20
11秒前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
TOWARD A HISTORY OF THE PALEOZOIC ASTEROIDEA (ECHINODERMATA) 1000
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
The Social Work Ethics Casebook(2nd,Frederic G. R) 600
Handbook of Social and Emotional Learning 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5118837
求助须知:如何正确求助?哪些是违规求助? 4324693
关于积分的说明 13473527
捐赠科研通 4157793
什么是DOI,文献DOI怎么找? 2278607
邀请新用户注册赠送积分活动 1280375
关于科研通互助平台的介绍 1219167